Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EPS (Weighted Average and Diluted) (2016 - 2025)

INVO Fertility (IVF) has disclosed EPS (Weighted Average and Diluted) for 15 consecutive years, with -$0.77 as the latest value for Q3 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 94.9% to -$0.77 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.44 through Sep 2025, up 106.98% year-over-year, with the annual reading at -$30.19 for FY2024, 55.19% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.77 at INVO Fertility, up from -$7.95 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $28.69 in Q4 2024, with the low at -$61.61 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$6.38, with a median of -$4.1 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 15266.67% in 2022, then skyrocketed 146.57% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.03 in 2021, then plummeted by 15266.67% to -$4.55 in 2022, then crashed by 1254.07% to -$61.61 in 2023, then skyrocketed by 146.57% to $28.69 in 2024, then plummeted by 102.68% to -$0.77 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.77, -$7.95, and -$12.53 for Q3 2025, Q2 2025, and Q1 2025 respectively.